CompFox AI Summary
The Workers' Compensation Appeals Board granted reconsideration and rescinded the original Findings and Award. The Board found that further development of the record was needed regarding the applicant's orthopedic permanent disability, specifically clarifying Dr. Bray's opinion on impairment and the application of Almaraz/Guzman II. Additionally, the Board determined that 10% of the psychiatric disability attributed to medication use should be considered industrial, reducing non-industrial apportionment from 30% to 20%. The matter was returned to the WCJ for further proceedings and a new decision on the deferred issues of permanent disability and attorney's fees.
Full Decision Text1 Pages
The Workers' Compensation Appeals Board granted reconsideration and rescinded the original Findings and Award. The Board found that further development of the record was needed regarding the applicant's orthopedic permanent disability, specifically clarifying Dr. Bray's opinion on impairment and the application of Almaraz/Guzman II. Additionally, the Board determined that 10% of the psychiatric disability attributed to medication use should be considered industrial, reducing non-industrial apportionment from 30% to 20%. The matter was returned to the WCJ for further proceedings and a new decision on the deferred issues of permanent disability and attorney's fees.
Read the full decision
Join + legal professionals. Create a free account to access the complete text of this decision and search our entire database.